Earnings call transcript: Coveo Solutions meets Q4 2026 expectations, stock dips

Coveo reported Q4 fiscal 2026 revenue of $37.4 million, up 9% year over year and slightly above the $37.46 million forecast, with EPS of -0.0542 in line with expectations. Gross margin held at 78%, adjusted EBITDA was $0.8 million, and operating cash flow was $13.7 million, while GenAI solutions grew to 13% of ARR and the company completed deprecation of the Qubit platform. Management guided fiscal 2027 SaaS subscription revenue to $154 million-$158 million and total revenue to $160 million-$164 million, but the stock fell 4.12% after hours amid cautious commentary and uncertainty around large strategic deal timing.

Analysis

Coveo is trying to re-rate from a low-growth legacy search vendor into a higher-multiple enterprise AI infrastructure name, and the market’s skepticism is still anchored in the old cohort mix. The key second-order effect is that the company is intentionally sacrificing near-term visibility from smaller, lower-velocity accounts to concentrate capital and sales coverage on larger deployments where one win can be worth several quarters of legacy bookings. That should improve future dollar-based expansion and deal size, but it also creates lumpier reported revenue and keeps the stock vulnerable to “good quarter, weak guide” reactions until the pipeline converts.

The more interesting implication is competitive: Coveo appears to be winning in an area where incumbents have strong brands but weaker product fit—permission-aware grounding across fragmented industrial and commerce data. That puts pressure on adjacent platforms like SAP, Salesforce, and even security-oriented AI vendors like PANW to prove they can deliver more than model access; customers now want relevance, governance, and monetizable workflows. If Coveo’s FDE-heavy motion works, the spillover is a widening moat via implementation complexity, not just search quality.

The main risk is timing, not demand. Large enterprise AI deals can move from pilot to revenue with a 6-18 month lag, so the next one or two quarters may still look noisy even if the underlying bookings engine is improving. The contrarian takeaway is that the post-earnings selloff may be more about model mechanics than fundamentals: a modest guide combined with a cleaner product mix and positive cash generation usually matters more for the next 12 months than the headline EPS print.

Catalysts are likely to be idiosyncratic: conversion of one or two seven-figure wins, evidence that GenAI monetization is expanding above current adoption rates, and any disclosure that strategic cohorts are outweighing the legacy drag faster than expected. Conversely, if the large-deal pipeline slips into H2 or the mature base churns harder than management suggests, the stock can underperform for multiple quarters despite improved strategic positioning.

Key Decisions for Investors

• Long CVO.TO on weakness over the next 1-2 weeks; use the post-earnings dip as entry, targeting a 3-6 month rerating if bookings convert and cash flow stays positive. Risk/reward is favorable if you size for event-driven volatility rather than linear growth.
• Pair trade: long CVO.TO / short a basket of legacy horizontal software names with weaker AI monetization narratives (e.g., CRM, SAP) for 3-6 months. The thesis is that platform value accrues to companies solving workflow grounding, not those simply adding copilots.
• Buy 3-6 month upside calls on CVO.TO rather than stock if available liquidly; the stock is likely to gap on large-contract announcements, while downside is capped by already depressed sentiment. Use a strike near the recent post-earnings level to avoid overpaying for delta.
• Monitor PANW and INTU for sentiment spillover: if Coveo’s enterprise AI messaging gains traction, it can support multiple names that own the workflow layer, but it is more likely to pressure vendors that are still narrating AI as feature add-ons. Use any strength in those names to trim if valuation is already stretched.
• If CVO.TO fails to hold post-earnings support over the next 2-4 weeks, fade the long and wait for a lower entry after the first Q1 update. The risk is not fundamental collapse; it is dead money while the market waits for evidence of revenue conversion.